Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs

Figure 3

Percentage of patients with putative protective antibody levels (≥1 mg/L) for serotype 23 F 6B and both 23 F and 6 B (C) at vaccination, at 4 to 6 weeks after vaccination, and at 1.5-year follow-up in patients with rheumatoid arthritis (RA) and spondyloarthropathy (SpA) treated with different antiinflammatory drugs.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us